Estrogen Receptor, c‐erbB‐2 and nm23/NDP Kinase Expression in the Intraductal and Invasive Components of Human Breast Cancers
Authors:
Open Access
- 26 August 1992
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 83 (8) , 859-865
Abstract
Expression of the c‐erbB‐2 oncoprotein (ErbB‐2) and the nm23 anti‐metastatic gene product (nucleoside diphosphate [NDP] kinase) was examined in the intraductal and invasive components of 63 fresh human breast cancer tissues. The expression of estrogen receptor (ER) as a marker of hormone dependency and the Ki‐67 protein as a proliferative cell marker was also examined. ErbB‐2 and ER were positive in 77.8% (28/36) and 64.7% (22/34) of the intraductal components, and in 43.6% (27/62) and 57.1% (36/63) of the invasive components, respectively. NDP kinase was positive in 58% (18/31) of intraductal, and in 30.9% (17/55) of invasive areas. The average Ki‐67‐positive cell rates were 5.9% in the intraductal, and 10.7% in the invasive components. Thus, the cells within the intraductal component of breast cancer appear to have different characteristics from the invasive component, not only in markers of proliferative ability, but also in the expression of oncogenes and hormone receptors.Keywords
This publication has 27 references indexed in Scilit:
- Overexpression of nucleoside diphosphate kinase (nm23) in solid tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- Positive Relationship Between Expression of Anti-metastatic Factor (nm23 Gene Product or Nucleoside Diphosphate Kinase) and Good Prognosis in Human Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Long‐term survival in breast cancer related to overexpression of the c‐erbB‐2 oncoprotein: An immunohistochemical study using monoclonal antibody NCL‐CB11The Journal of Pathology, 1991
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- ASSOCIATION OF LOW NM23 RNA LEVELS IN HUMAN PRIMARY INFILTRATING DUCTAL BREAST CARCINOMAS WITH LYMPH-NODE INVOLVEMENT AND OTHER HISTOPATHOLOGICAL INDICATORS OF HIGH METASTATIC POTENTIAL1989
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Prognostic factors for recurrence and survival in axillary node-negative breast cancerJournal of Steroid Biochemistry, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Evidence for a Novel Gene Associated With Low Tumor Metastatic PotentialJNCI: Journal of the National Cancer Institute, 1988
- A Mr=190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the C-erbB-2 geneBiochemical and Biophysical Research Communications, 1987